Rebekka Van Hoof obtained her master’s degree in Biochemistry and Biotechnology at the KU Leuven. Currently she is a PhD candidate at the VITO Health Diagnostics group in collaboration with the Laboratory for Soft Matter and Biophysics at the KU Leuven and the Theory Lab as well as the Data Science Institute at UHasselt. She researches the development of technologies and sensors for the targeted detection of nucleic acid mutation derived from extracellular vesicles, a biomarker in liquid biopsies.